Profile: OraPharma, Inc. specializes in the emerging field of oral health care. We discover, develop and commercialize therapeutics for oral health. We specialize in the production of Arestin®, which represents a promising therapeutic advance for the adjunct treatment of periodontal disease. It is the first locally administered time-released antibiotic encapsulated in micro spheres that effectively kills the germs that cause periodontal disease or periodontitis. It uses new micro sphere technology to easily and effectively kill the germs that cause periodontal disease.